Fen-Phen Heart Health Risks

Fen-Phen, or fenfluramine/phentermine, was a diet drug combination used by millions of patients until it was removed from the market. Although the drug has not been available for years, it has been linked to serious heart health risks that can affect patients long after they used the drug.

Ferrer, Poirot & Wansbrough can help if you or someone you love was diagnosed with heart valve damage after using Fen-Phen. We fight to protect the rights of drug injury victims. But our Fen-Phen Injury lawyers can't begin working on your case until you speak with us. Contact our legal staff today—just dial (800) 210-8503 or complete a free initial consultation form.

Adverse Fen-Phen Health Effects

The U.S. Food and Drug Administration (FDA) withdrew Fen-Phen from the market in 1997 following numerous reports of valvular heart disease—a disease affecting one or more of the heart’s valves—and other drug injuries in patients who were being treated with or had been treated with the drug.

More than a decade after the FDA pulled Fen-Phen, the medical journal BMC Medicine published research suggesting an increased risk of heart valve injury in people who had used Fen-Phen in years prior. Heart valve failure can lead to a backflow of blood within the heart, called regurgitation, which can lead to congestive heart failure and the need for heart valve surgery.

Researchers found a sevenfold increase in the risk for heart valve surgery among former fenfluramine users, adding that this estimate may be conservative in light of another study showing higher increased risk of heart valve disease among patients who had used fenfluramines for four months or longer.

Take Legal Action

If you’ve suffered heart valve damage after taking Fen-Phen, we’re here for you. At Ferrer, Poirot & Wansbrough, we force corporations to put responsibility over profits. And you won’t pay out of pocket costs unless we get money for you. So don’t wait, contact our legal staff today. We’re available to take your call 24 hours a day, seven days a week.

This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration or BMC Medicine.